Open AccessThis article is
- freely available
CD81 and Hepatitis C Virus (HCV) Infection
Center for Infection and Immunity of Lille, CNRS-UMR8204, Inserm-U1019, Institut Pasteur de Lille, Université Lille Nord de France, Institut de Biologie de Lille, 1 rue du Pr Calmette, CS50447, 59021 Lille Cedex, France
Department of Medicine, Division of Oncology, CCSR, Stanford University Medical Center, Stanford, CA 94305, USA
* Author to whom correspondence should be addressed.
Received: 24 December 2013; in revised form: 29 January 2014 / Accepted: 2 February 2014 / Published: 6 February 2014
Abstract: Hepatitis C Virus (HCV) infection is a global public health problem affecting over 160 million individuals worldwide. Its symptoms include chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. HCV is an enveloped RNA virus mainly targeting liver cells and for which the initiation of infection occurs through a complex multistep process involving a series of specific cellular entry factors. This process is likely mediated through the formation of a tightly orchestrated complex of HCV entry factors at the plasma membrane. Among HCV entry factors, the tetraspanin CD81 is one of the best characterized and it is undoubtedly a key player in the HCV lifecycle. In this review, we detail the current knowledge on the involvement of CD81 in the HCV lifecycle, as well as in the immune response to HCV infection.
Keywords: Hepatitis C Virus; CD81; tetraspanins; entry factors; viral lifecycle; immune response
Citations to this Article
Cite This Article
MDPI and ACS Style
Fénéant, L.; Levy, S.; Cocquerel, L. CD81 and Hepatitis C Virus (HCV) Infection. Viruses 2014, 6, 535-572.
Fénéant L, Levy S, Cocquerel L. CD81 and Hepatitis C Virus (HCV) Infection. Viruses. 2014; 6(2):535-572.
Fénéant, Lucie; Levy, Shoshana; Cocquerel, Laurence. 2014. "CD81 and Hepatitis C Virus (HCV) Infection." Viruses 6, no. 2: 535-572.